Author:
Goya Stephanie,Ruis Christopher,Neher Richard A.,Meijer Adam,Aziz Ammar,Hinrichs Angie S.,von Gottberg Anne,Roemer Cornelius,Amoako Daniel G.,Acuña Dolores,McBroome Jakob,Otieno James R.,Bhiman Jinal N.,Everatt Josie,Muñoz-Escalante Juan C.,Ramaekers Kaat,Duggan Kate,Presser Lance D.,Urbanska Laura,Venter Marietjie,Wolter Nicole,Peret Teresa C.T.,Salimi Vahid,Potdar Varsha,Borges Vítor,Viegas Mariana
Publisher
Centers for Disease Control and Prevention (CDC)
Reference47 articles.
1. European Medicine Agency. Arexvy. 2023 [cited 2024 Jun 28]. https://www.ema.europa.eu/en/medicines/human/EPAR/arexvy
2. US Food and Drug Administration. Abrysvo. 2023 [cited 2024 Jun 28]. https://www.fda.gov/vaccines-blood-biologics/abrysvo
3. US Food and Drug Administration. Nirsevimab. 2023 [cited 2023 Nov 12]. https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-prevent-rsv-babies-and-toddlers
4. Proposal for human respiratory syncytial virus nomenclature below the species level.;Salimi;Emerg Infect Dis,2021
5. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.;Anderson;J Infect Dis,1985
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献